Clinical Trial

Proton Therapy in Reducing Toxicity in Anal Cancer

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this research study is to determine whether the amount of radiation given to the normal areas around the anal cancer can be reduced by using Proton Therapy while reducing the side effects that are seen with standard therapy.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2017-01-10; most recent amendment 2024-08-21.
Status change: Recruiting → Active, Not Recruiting 2021-06-30
Trial Details
NCT Number NCT03018418
Lead Sponsor Jordan Kharofa
Conditions Anus Neoplasms
Enrollment 14 participants
Start Date 2017-01-04
Primary Completion 2022-04-07 (estimated)
Study Completion 2025-07-01 (estimated)
Updated on ClinicalTrials.gov 2024-09-19